Biocon Biologics Limited, a active public limited company, was established on 08 June 2016 in Bengaluru, Karnataka, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24119KA2016PLC093936. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹3,500.00 Cr and a paid-up capital of ₹1,758.31 Cr.
Formerly known as Biocon Biologics India Limited. It upholds a compliant status. Employing 5,280 professional, Its leadership includes Bobby Kanubhai Parikh (Director), Kiran Mazumdar Shaw (Whole-Time Director), Daniel Mark Bradbury (Director). Past directors included Bobby Kanubhai Parikh, John Russell Fotheringham Walls, Kiran Mazumdar Shaw. It holds ₹9,543.66 Cr open charges and ₹18,987.20 Cr settled loans. Its latest AGM occurred on 25 July 2025, with the balance sheet filed on 31 March 2025. It is based at Biocon House, Ground Floor, Tower-3, Semicon Park Electronic City, Phase - Ii, Hosur Road, Bengaluru, Karnataka, 560100.
U24119KA2016PLC093936
093936
08 June 2016
₹3,500.00 Cr
₹1,758.31 Cr
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Biocon Biologics Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bobby Kanubhai Parikh | Director | 01 Aug 2019 | Current |
| Kiran Mazumdar Shaw | Whole-Time Director | 08 Jun 2016 | Current |
| Daniel Mark Bradbury | Director | 01 Aug 2019 | Current |
| Rajiv Malik | Nominee Director | 29 Nov 2022 | Current |
| Peter Baron Piot | Director | 21 Jan 2021 | Current |
| Shreehas Pradeep Tambe | Ceo | 05 Dec 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 24 Jul 2020 | Past |
| Pramod Abcsdd | Director | 07 Jun 2024 | Past |
| Pramod Abcsdd | Director | 21 Jan 2021 | Past |
| Pramod Abcsdd | Company Secretary | 15 Mar 2019 | Past |
| Pramod Abcsdd | Cfo(Kmp) | 23 Oct 2019 | Past |
| Pramod Abcsdd | Additional Director | 24 Jul 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Biocon Biologics Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 7.73% decrease. The company also saw a substantial fall in profitability, with a 617.79% decrease in profit. The company's net worth Soared by an impressive increase of 691.55%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Biocon Biologics had a promoter holding of 92.04% and a public holding of 7.96%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹95,436,558,080.00
₹189,872,015,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Dec 2024 | Others | ₹2,734.90 Cr | Open |
| 22 Nov 2024 | Others | ₹6,808.76 Cr | Open |
| 06 Mar 2023 | The Hongkong And Shanghai Banking Corporation Limited | ₹9,841.76 Cr | Satisfied |
| 03 Mar 2023 | Others | ₹7,947.94 Cr | Satisfied |
| 13 Sep 2021 | Others | ₹200.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Biocon Biologics has a workforce of 5280 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Biocon Biologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biocon Biologics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Biocon Biologics Limited last Annual general meeting of members was held on 25 Jul 2025 as per latest MCA records. was recorded as a recent event.
The activity Biocon Biologics Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was completed.
A charge registered on 03 Mar 2023 via Charge ID 100692461 with Others was fully satisfied on 09 Jan 2025. was recorded as a recent event.
A charge registered on 30 Oct 2020 via Charge ID 100386601 with The Hongkong And Shanghai Banking Corporation Limited was fully satisfied on 07 Jan 2025. was recorded as a recent event.
Progress on A charge registered on 14 Dec 2018 via Charge ID 100224925 with Others was fully satisfied on 06 Jan 2025. was documented.
Progress on A charge with Others of Rs. 2,734.90 Cr registered on 09 Dec 2024 with Charge ID 101019160 was modified on 30 Dec 2024. was documented.
The CIN of Biocon Biologics Limited is U24119KA2016PLC093936.
Biocon Biologics Limited is headquartered at Biocon House, Ground Floor, Tower-3, Semicon Park Electronic City, Phase - Ii, Hosur Road, Bengaluru, Karnataka, 560100.
Biocon Biologics Limited was incorporated on 08 June 2016.
The current directors of Biocon Biologics Limited are
The primary industry of Biocon Biologics Limited is Manufacturing.
Biocon Biologics Limited is unlisted.
The authorized capital of Biocon Biologics Limited is ₹3,500.00 Cr, and the paid-up capital is ₹1,758.31 Cr.
The compliance status of Biocon Biologics Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX